These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 18279936)
1. Incidence of local and port site recurrence of urologic cancer after laparoscopic surgery. Tanaka K; Hara I; Takenaka A; Kawabata G; Fujisawa M Urology; 2008 Apr; 71(4):728-34. PubMed ID: 18279936 [TBL] [Abstract][Full Text] [Related]
2. Oncological safety of laparoscopic surgery for urological malignancy: experience with more than 1,000 operations. Rassweiler J; Tsivian A; Kumar AV; Lymberakis C; Schulze M; Seeman O; Frede T J Urol; 2003 Jun; 169(6):2072-5. PubMed ID: 12771722 [TBL] [Abstract][Full Text] [Related]
3. [Retroperitoneal laparoscopic surgery and carcinogenic risk]. Cicco A; Salomon L; Saint F; Hoznek A; Chopin D; Abbou CC Prog Urol; 2001 Feb; 11(1):8-15. PubMed ID: 11296653 [TBL] [Abstract][Full Text] [Related]
4. Tumor seeding in urological laparoscopy: an international survey. Micali S; Celia A; Bove P; De Stefani S; Sighinolfi MC; Kavoussi LR; Bianchi G J Urol; 2004 Jun; 171(6 Pt 1):2151-4. PubMed ID: 15126775 [TBL] [Abstract][Full Text] [Related]
5. Incidence of local recurrence and port site metastasis after laparoscopic radical nephroureterectomy. Muntener M; Schaeffer EM; Romero FR; Nielsen ME; Allaf ME; Brito FA; Pavlovich CP; Kavoussi LR; Jarrett TW Urology; 2007 Nov; 70(5):864-8. PubMed ID: 18068440 [TBL] [Abstract][Full Text] [Related]
13. Port site metastasis after laparoscopic radical nephrectomy: a single-center experience. Kumar V; Mandhani A; Srivastava A; Ansari MS; Singh UP; Kapoor R Indian J Cancer; 2012; 49(1):102-6. PubMed ID: 22842176 [TBL] [Abstract][Full Text] [Related]
14. Port site metastases after robot-assisted laparoscopic radical cystectomy. El-Tabey NA; Shoma AM Urology; 2005 Nov; 66(5):1110. PubMed ID: 16286145 [TBL] [Abstract][Full Text] [Related]
15. Laparoscopic radical nephroureterectomy for upper tract transitional cell carcinoma: oncological outcomes at 7 years. Berger A; Haber GP; Kamoi K; Aron M; Desai MM; Kaouk JH; Gill IS J Urol; 2008 Sep; 180(3):849-54; discussion 854. PubMed ID: 18635229 [TBL] [Abstract][Full Text] [Related]
16. Laparoscopic retroperitoneal lymph node dissection: does it still have a role in the management of clinical stage I nonseminomatous testis cancer? A European perspective. Rassweiler JJ; Scheitlin W; Heidenreich A; Laguna MP; Janetschek G Eur Urol; 2008 Nov; 54(5):1004-15. PubMed ID: 18722704 [TBL] [Abstract][Full Text] [Related]
17. A multi-institution, minimally invasive urological oncology fellowship: a critical assessment of the clinical training and academic benefits. Brown JA; Lewis RW J Urol; 2006 Dec; 176(6 Pt 1):2619-23; discussion 2623. PubMed ID: 17085174 [TBL] [Abstract][Full Text] [Related]
18. Low incidence of port-site metastases after laparoscopic staging of uterine cancer. Martínez A; Querleu D; Leblanc E; Narducci F; Ferron G Gynecol Oncol; 2010 Aug; 118(2):145-50. PubMed ID: 20451983 [TBL] [Abstract][Full Text] [Related]
19. The rate of port-site metastases after 2251 laparoscopic procedures in women with underlying malignant disease. Zivanovic O; Sonoda Y; Diaz JP; Levine DA; Brown CL; Chi DS; Barakat RR; Abu-Rustum NR Gynecol Oncol; 2008 Dec; 111(3):431-7. PubMed ID: 18929404 [TBL] [Abstract][Full Text] [Related]